Tsumura & Co
TSE:4540
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 600.5
5 070
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Tsumura & Co
Tsumura & Co
Cash & Cash Equivalents
Tsumura & Co
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Tsumura & Co
TSE:4540
|
Cash & Cash Equivalents
¥82.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash & Cash Equivalents
¥859B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash & Cash Equivalents
¥707.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash & Cash Equivalents
¥515.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash & Cash Equivalents
¥462.9B
|
CAGR 3-Years
34%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Cash & Cash Equivalents
¥302.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-2%
|
|
Tsumura & Co
Glance View
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 3,830 full-time employees. Through its subsidiaries, the Company is also engaged in the procurement, sorting and processing of crude drugs, the manufacture and sale of Chinese herbal extract powders and drug substances, the operation of dispensing pharmacies and the provision of logistics services, as well as the development of pharmaceuticals.
See Also
What is Tsumura & Co's Cash & Cash Equivalents?
Cash & Cash Equivalents
82.4B
JPY
Based on the financial report for Sep 30, 2024, Tsumura & Co's Cash & Cash Equivalents amounts to 82.4B JPY.
What is Tsumura & Co's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
14%
Over the last year, the Cash & Cash Equivalents growth was 1%. The average annual Cash & Cash Equivalents growth rates for Tsumura & Co have been 7% over the past three years , 4% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
